Dragan Cicic

Insider Reports History

Entity
Individual
Location
C/O Actinium Pharmaceuticals, Inc, 546 Fifth Avenue, 14 Th Floor, New York, NY
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: Dragan Cicic
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dragan Cicic:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SELLAS Life Sciences Group, Inc. SVP, Chief Development Officer Common Stock 310K $350K $1.13 Jan 10, 2025 Direct
SELLAS Life Sciences Group, Inc. SVP, Chief Development Officer Stock Option (Right to Buy) 170K Jan 10, 2025 Direct

Insider Reports Filed by Dragan Cicic

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLS SELLAS Life Sciences Group, Inc. Jan 10, 2025 3 $0 4 Jan 14, 2025 SVP, Chief Development Officer
SLS SELLAS Life Sciences Group, Inc. Dec 4, 2024 1 -$9.33K 4 Dec 5, 2024 SVP, Chief Development Officer
SLS SELLAS Life Sciences Group, Inc. Jun 20, 2024 0 $0 3 Jun 27, 2024 SVP, Chief Development Officer